Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
This PHASE1/PHASE2 trial investigates Alcohol Dependence and is currently completed. National Institute on Alcohol Abuse and Alcoholism (NIAAA) leads this study, which shows 12 recorded versions since 2009 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE1_PHASE2
-
Dec 2021 — Dec 2022 [monthly]
Completed PHASE1_PHASE2
▶ Show 7 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE1_PHASE2
-
Aug 2020 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
Phase: PHASE1 → PHASE1_PHASE2
-
Nov 2019 — Aug 2020 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed · Phase: PHASE1_PHASE2 → PHASE1
-
Oct 2018 — Nov 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jun 2018 — Oct 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jan 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Jan 2018 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Sep 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- National Institutes of Health (NIH)
- Yale University
For direct contact, visit the study record on ClinicalTrials.gov .